See Phan
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 8
- Peptidase Inhibition and Analysis 2
- Colorectal Cancer Treatments and Studies 2
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- David S. Shames (8 shared papers)Tony Mok (6 shared papers)Mark L. McCleland (5 shared papers)Francesco Orlandi (4 shared papers)Makoto Nishio (4 shared papers)Dustin Smith (3 shared papers)Ticiana Leal (3 shared papers)Simonetta Mocci (5 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Journal of Thoracic Oncology (4 papers)Clinical Lung Cancer (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
See Phan
22 papers receiving 1.8k citations
See Phan's Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.0k
- Hepatology 167
- Genetics 152
- Cancer Research 207
Countries citing papers authored by See Phan
This map shows the geographic impact of See Phan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by See Phan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites See Phan more than expected).
Fields of papers citing papers by See Phan
This network shows the impact of papers produced by See Phan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by See Phan. The network helps show where See Phan may publish in the future.
Co-authors
The 25 scholars most cited alongside See Phan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133) Hit paper breakdown → | 2021 | 484 |
| 2 | Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial Hit paper breakdown → | 2020 | 290 |
| 3 | 2017 | 232 | |
| 4 | 2016 | 209 | |
| 5 | 2008 | 124 | |
| 6 | 2002 | 122 | |
| 7 | 2021 | 114 | |
| 8 | 2022 | 111 | |
| 9 | 2018 | 35 | |
| 10 | 2016 | 34 | |
| 11 | 2004 | 28 | |
| 12 | 2016 | 27 | |
| 13 | 2019 | 12 | |
| 14 | 2020 | 11 | |
| 15 | Atezolizumab Plus Chemotherapy for First-Line Treatment of Non-Squamous Non-Small Cell Lung Cancer: Results From the Randomized Phase III IMpower132 Trial. | 2020 | 7 |
| 16 | 2019 | 7 | |
| 17 | 2020 | 4 | |
| 18 | 2017 | 3 | |
| 19 | 2016 | 2 | |
| 20 | 2020 | 2 |
About See Phan
See Phan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Molecular Biology, having authored 22 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Research Studies (8 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.0k citations), Hepatology (167 citations), Genetics (152 citations) and Cancer Research (207 citations). See Phan has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include David S. Shames, Tony Mok, Mark L. McCleland, Francesco Orlandi, Makoto Nishio, Dustin Smith, Ticiana Leal, Simonetta Mocci, David R. Spigel and Niels Reinmuth. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Lung Cancer, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.